semaglutide supplements Compounded (GLP-1) GLP-1 Drugs from the Gray

Description

Almost all diseases and drug treatments are inevitably associated with side effects, such as nausea and vomiting

The results from SELECT will be instrumental in changing the way we perceive and treat obesity, said Martin Lange, executive vice president and head of Development at Novo Nordisk

doi:10.1016/S0140-6736(19)31149-3

15 Both dysbiosis and impaired gut integrity have been strongly associated with the development of overweight, obesity and metabolic syndrome, and should be a key focus of therapeutic protocols either independent of or alongside GLP-1 agonist therapy in supporting weight management